Anthropic's $2 Trillion IPO and the Retail Access Gap: What Bill Ackman's New Fund Really Changes

The regret that built a fund

There's a specific kind of investing regret that almost everyone recognizes. You watched a company become a household name — SpaceX, say — and by the time you could actually buy a share, the easy money had already been made by insiders who got in years earlier at a fraction of the price.

Bill Ackman has heard that complaint enough times to build a business around it. On Pershing Square's second-quarter earnings call on August 13, 2026, the billionaire made the frustration explicit: the average investor's first shot at a company like SpaceX often comes at a $1.5 trillion valuation, while he was able to invest in SpaceX, X, and xAI at far lower prices. His stated goal, in his own words, is to "give that opportunity to the average person on the street."

That's the pitch for Pershing Square Ventures Ltd., a new fund the firm is targeting to launch by the fall or end of 2026, with a planned filing with the U.S. Securities and Exchange Commission.

It's a genuinely interesting development. But before you get excited, it's worth being precise about what Ackman announced — because the headline version circulating online gets it slightly wrong, and the difference matters for your money.

What Ackman actually announced (and what he didn't)

The loose version of this story is: Ackman wants to let normal investors buy into the Anthropic IPO before the IPO. That's not quite right.

What Ackman is building is an evergreen permanent-capital vehicle. In plain English, that means a fund with no fixed end date. Traditional private equity funds have a lifespan — they raise money, invest it, and are forced to sell and return capital on a schedule. An evergreen fund can buy a company while it's still private and simply keep holding it after it goes public, without a countdown clock forcing a sale around the IPO.

That structure is the whole point. A conventional pre-IPO vehicle often has to dump shares right around the listing, exactly when prices are most volatile. An evergreen fund doesn't.

Two other design choices are worth understanding. First, Pershing Square Ventures will be seeded with private investments already sitting on Pershing Square's balance sheet, plus some from Ackman's own family office. That answers the classic complaint about blank-check vehicles and SPACs: with those, you're often handing money to a manager before you know what they'll buy. Here, you'd know what you own from day one. Second, the fund's target range is broad — from companies worth a few hundred million dollars up to "decacorns" valued above $10 billion.

So the accurate framing is this: Ackman is not handing retail investors a ticket to the Anthropic IPO. He's creating a fund that will own private companies — potentially including names like Anthropic and OpenAI — and letting ordinary investors buy into that fund. You're buying Ackman's portfolio and his judgment, not a direct slice of any single company.

That's a meaningful distinction. It's also, honestly, a more sensible product than the "let everyone pile into one hot IPO" fantasy the headlines imply.

Why now: the pre-IPO wave and the $2 trillion elephant

Ackman isn't acting in a vacuum. Pershing Square Ventures is arriving in the middle of a broader rush to sell retail investors access to private markets. Several closed-end funds focused on private companies have gone public in 2026 alone, including two vehicles from Robinhood and the Fundrise Innovation Fund. The demand is real and growing.

And it's growing for an obvious reason: the largest private companies in history are all approaching the public markets at once.

The elephant is Anthropic. The company filed a confidential draft registration statement (an S-1) with the SEC on June 1, 2026, formally starting the IPO clock. Its most recent private valuation was $965 billion, set in a May 2026 round that raised $65 billion from investors including Altimeter, Dragoneer, Greenoaks, and Sequoia. Since then, its numbers have moved fast: Bloomberg reported in mid-August that Anthropic's annualized revenue run rate had surpassed $65 billion, with some investor projections putting full-year 2026 revenue at $100 billion to $120 billion.

On the back of that trajectory, investors are now targeting a listing valuation near $2 trillion as early as October 2026, according to the Financial Times. If it happens at that level, it would be the largest IPO ever — surpassing SpaceX's roughly $1.77 trillion debut earlier in the year. Anthropic is reportedly working with Morgan Stanley, Goldman Sachs, and JPMorgan, and is expected to list on the Nasdaq.

That $2 trillion figure comes from investors and bankers, not from Anthropic itself. No senior executive has publicly confirmed a valuation target. Treat it as market expectation, not company guidance.

There's also OpenAI running in parallel — it filed its own confidential S-1 in June 2026 — and the timing between the two could matter. A successful Anthropic debut might warm sentiment for OpenAI, or it might soak up the capital that would otherwise flow there.

The SpaceX warning label

Here's the part the "get in early" crowd tends to skip. Getting in early is only good if you get in at a good price.

Look at what happened with SpaceX. The stock debuted on June 12 at $135 a share, surged to over $225 within days, then fell more than 50% from that peak before partially recovering after earnings. Investors who bought at the IPO price got a stomach-churning ride. Investors who bought years earlier at private valuations had an entirely different experience.

That's the whole game in one example. The advantage insiders have isn't magic — it's entry price. And it's precisely why Ackman's seeded-portfolio, buy-and-hold structure is smarter than a blank-check bet: outcomes in this space depend heavily on the valuation you pay going in. A vehicle that buys a company at $2 trillion on IPO day is not giving you an insider's edge. It's giving you a retail investor's price with extra steps.

So what can a normal investor actually do today?

If you want some Anthropic exposure right now, here's the honest menu. None of it is a clean, direct purchase — that option doesn't exist for the general public yet.

• —Thematic and private-market ETFs. A few publicly traded ETFs already hold small Anthropic positions. Fred Alger Management's Concentrated Equity ETF (CNEQ) reportedly holds the largest Anthropic weighting among the commonly cited options — and even there, Anthropic is less than 4% of the fund. Alger also includes it in its Alger 35 (ATFV) and AI Enablers & Adopters (ALAI) ETFs. The KraneShares Public-Private AI & Technology ETF (AGIX) and the T. Rowe Price Technology ETF (TTEQ) offer exposure to a basket of private AI names. The catch is simple math: putting $1,000 into one of these funds does not put $1,000 into Anthropic.
• —Closed-end and interval funds. Vehicles like the Fundrise Innovation Fund have offered a cheaper entry point into a portfolio of late-stage private companies. These trade differently from ordinary stocks and can carry higher fees and liquidity restrictions, so read the fine print.
• —Indirect exposure through public partners. Amazon has invested billions and is a major cloud partner; Alphabet holds a significant stake and provides compute; Salesforce has participated through its venture arm. Owning those stocks gives you a highly diluted, indirect tie to Anthropic's success — but you're mostly buying Amazon or Alphabet, not Anthropic.
• —Secondary markets (accredited investors only). If you meet the SEC's income or net-worth thresholds, marketplaces like Forge Global and Hiive let you buy private shares from existing holders. For reference, Nasdaq Private Market pegged Anthropic shares around $692 in mid-August. This route is closed to most people by design.
• —Ackman's fund, eventually. Once Pershing Square Ventures launches and files with the SEC, it may become another route — but details, fees, and the actual holdings will matter enormously. Wait to see the terms before deciding it's a fit.

The bottom line

The most valuable thing to take from this moment isn't a ticker symbol. It's a mental model.

The "retail access gap" is real: the biggest gains in companies like Anthropic accrue to whoever bought earliest and cheapest, and that has historically excluded ordinary investors. New products from Ackman and others are genuinely trying to narrow that gap, and that's worth watching. But every one of them still runs into the same law of gravity — the price you pay determines the return you earn. A shiny new fund that buys in at a record valuation hasn't beaten the gap; it's just repackaged it.

Be curious about these vehicles. Be skeptical of any pitch that promises insider access without insider prices. And when the Anthropic IPO finally rings the bell, remember the SpaceX chart before you chase the first-day pop.

Not financial advice — educational only. This article is general information, not a recommendation about any security or strategy. Consider your own circumstances and speak with a licensed professional.